Bio or Pharma — Which side are you on?

With healthcare reform, biosimilar legislation and pharma-industry taxation among the topics perking along in Washington this summer, it’s important for life sciences companies to present a unified front to legislators. Thus, it doesn’t appear to be a casual decision by […]

Read More

HCPC to hold membership-drive webinar

Unit-dose packaging (aka “compliance” packaging) remains—as it has been for many years—the preferred packaging system in Europe and other parts of the world, but an also-ran in the United States. The reasons for this are manyfold: Compliance packaging tends to […]

Read More

LifeScience’s shared-utility infrastructure delivers 99.98% inventory accuracy to its customers Today, biotechnology is the fastest-growing segment of biopharma. It has created more than 200 new therapies and vaccines, including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders, and has […]

Read More

LifeScience’s shared-utility infrastructure delivers 99.98% inventory accuracy to its customers Today, biotechnology is the fastest-growing segment of biopharma. It has created more than 200 new therapies and vaccines, including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders, and has […]

Read More